Advanced search
Publication Cover
Expert Review of Vaccines Volume 12, 2013 - Issue 9
Submit an article Journal homepage
482
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Potential of the adhesin complex protein of Neisseria meningitidis for next-generation meningococcal vaccines

Miao-Chiu HungNeisseria Research, Molecular Microbiology, Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, SO166YD, [email protected]
,
John E HeckelsNeisseria Research, Molecular Microbiology, Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, SO166YD, [email protected]
&
Myron ChristodoulidesNeisseria Research, Molecular Microbiology, Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, SO166YD, [email protected]
Pages 981-984 | Published online: 09 Jan 2014

References

  • Tan LK, Carlone GM, Borrow R. Current concepts. Advances in the development of vaccines against Neisseria meningitidis. N. Engl. J. Med. 362(16), 1511–1520 (2010).
  • Granoff DM. Review of meningococcal group B vaccines. Clin. Infect. Dis. 50, S54–S65 (2010).
  • Williams JN, Skipp PJ, O'Connor CD, Christodoulides M, Heckels JE. Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates. Infect. Immun. 77(11), 5080–5089 (2009).
  • Echenique-Rivera H, Muzzi A, Del Tordello E et al. Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog. 7(5), e10002027 (2011).
  • Rappuoli R, Black S, Lambert PH. Vaccine discovery and translation of new vaccine technology. Lancet 378(9788), 360–368 (2011).
  • Dormitzer PR, Grandi G, Rappuoli R. Structural vaccinology starts to deliver. Nat. Rev. Microbiol. 10(12), 807–813 (2012).
  • Tettelin H, Saunders NJ, Heidelberg J et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287(5459), 1809–1815 (2000).
  • Giuliani MM, du-Bobie J, Comanducci M et al. A universal vaccine for serogroup B meningococcus. Proc. Natl Acad. Sci. USA 103(29), 10834–10839 (2006).
  • Mcneil LK, Zagursky RJ, Lin SL et al. Role of Factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol. Mol. Biol. Rev. 77(2), 234–252 (2013).
  • Vogel U, Taha MK, Vazquez JA et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect. Dis. 13(5), 416–425 (2013).
  • Bettinger JA, Scheifele DW, Halperin SA et al. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB). Vaccine (2013) ( Epub ahead of print).
  • Post DM, Zhang D, Eastvold JS, Teghanemt A, Gibson BW, Weiss JP. Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J. Biol. Chem. 280(46), 38383–38394 (2005).
  • Ferrari G, Garaguso I, Adu-Bobie J et al. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 6(6), 1856–1866 (2006).
  • Williams JN, Skipp PJ, Humphries HE, Christodoulides M, O'Connor CD, Heckels JE. Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant. Infect.Immun. 75(3), 1364–1372 (2007).
  • Grifantini R, Sebastian S, Frigimelica E et al. Identification of iron-activated and – repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B. Proc. Natl Acad. Sci. USA 100(16), 9542–9547 (2003).
  • Adu-Bobie J, Lupetti P, Brunelli B et al. GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence. Infect. Immun. 72(4), 1914–1919 (2004).
  • Ren J, Sainsbury S, Combs SE et al. The structure and transcriptional analysis of a global regulator from Neisseria meningitidis. J. Biol. Chem. 282(19), 14655–14664 (2007).
  • Hung MC, Heckels JE, Christodoulides M. The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential. MBIO 4(2), e00041:13 (2013).
  • Myers GS, Parker D, Al-Hasani K et al. Genome sequence and identification of candidate vaccine antigens from the animal pathogen Dichelobacter nodosus. Nat.Biotechnol. 25(5), 569–575 (2007).
  • Franzoso S, Mazzon C, Sztukowska M et al. Human monocytes/macrophages are a target of Neisseria meningitidis Adhesin A (NadA). J. Leukoc. Biol. 83(5), 1100–1110 (2008).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.